Editor's note: Welcome to Stockpickr's "Barron's Roundup." Each weekend, James Altucher presents Stockpickr portfolios related to articles in the latest issue of Barron's.

Four Health-Care Picks

:

Barron's

highlights four health-care stocks that could be winners in a slowing economy. Names mentioned include

Express Scripts

(ESRX)

and

Teva Pharmaceutical Industries

(TEVA) - Get Report

.

Small-Cap Value

:

Barron's

speaks with value investor Robert Fetch, portfolio manager of the

Lord Abbett Small Cap Value Fund

. Fetch tells

Barron's

he's finding valuations in the market he hasn't seen in decades. Names he likes include

Plexus

(PLXS) - Get Report

and

URS

(URS)

.

Speaking of Dividends

: This

Barron's

column highlights the latest dividend increases, initiations and cutbacks. This week there's information on

Sysco

(SYY) - Get Report

and

Roper Industries

(ROP) - Get Report

.

Bullish and Bearish

: Each week,

Barron's

publishes bullish and bearish stories on a variety of stocks. We present summaries of those stories in this portfolio. This week, there are bullish stories on

Berkshire Hathaway

(BRK.A) - Get Report

and

Yahoo!

(YHOO)

, plus a bearish piece on

National Financial Partners

(NFP)

.

Latest Activist Purchases

: Which companies are the top hedge funds chasing? This week's list includes names like

Delta Petroleum

( DPTR),

AutoNation

(AN) - Get Report

and

Enzon Pharmaceuticals

(ENZN)

.

Research Reports

: The latest analyst research highlighted by

Barron's

, including reports this week on

Home Depot

(HD) - Get Report

,

Intel

(INTC) - Get Report

and

Natus Medical

(BABY)

.

Top Insider Purchases of the Week

: Insider purchases are a lot more predictive than insider selling.

Barron's

lists companies where managers are buying stock, and we build a portfolio with those companies' stocks. There has been interesting activity in

Citigroup

(C) - Get Report

,

Invitrogen

( IVGN),

General Electric

(GE) - Get Report

and

EnergySolutions

(ES) - Get Report

.

At the time of publication, Altucher and/or his fund had no holdings of stocks mentioned, although positions may change at any time.

James Altucher is president of

Stockpickr

LLC, a wholly owned subsidiary of TheStreet.com and part of its network of Web properties, and a managing partner at Formula Capital, an alternative asset management firm that runs a fund of hedge funds. He is also a weekly columnist for the

Financial Times

and the author of

Trade Like a Hedge Fund

,

Trade Like Warren Buffett

and

SuperCa$h

. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback;

click here

to send him an email.

TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.